instruction stringlengths 732 1.39k | output stringlengths 651 861 |
|---|---|
SUBJECT: Clinical observation with Product A and supply inquiry
BODY:
Dear Customer Support,
As the head of pharmacy procurement for a regional health trust and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 71 year old male with benig... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient experienced a sharp drop in platelet count observed on day 7 lab work temporally associated with Product A initiation, with clinical intervention ta... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I am writing to formally report two distinct matters. Regarding Product ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the bioequivalence data for... |
SUBJECT: Co-therapy observation and commercial query on Product A and Product B
BODY:
Dear Pharmacy Director,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. and I am writing to raise two distinct concerns. The first is a... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal functio... |
SUBJECT: Urgent issue regarding Product A and institutional inquiry
BODY:
Dear Post-Market Surveillance,
I am the clinical lead pharmacist at a large teaching hospital and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Can you confirm the shelf life and beyon... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you confirm the shelf life and beyond-us... |
SUBJECT: Safety and quality note on Product A and supply inquiry
BODY:
Dear Quality and Commercial Teams,
I am the prescribing advisor for a mental health trust and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 58 year old male with COPD. He had... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient had a generalized tonic-clonic seizure approximately 12 hours after the evening dose temporally associated with Product A initiation, with clinical ... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Drug Safety Department,
Our hospital pharmacist network reviews dual-product regimens including Product A for infectious disease and Product B for prophylactic gastroprotection. I have two separate matters to raise. Firstly re... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide the pharmacokinetic ... |
SUBJECT: Cross-product clinical and quality note on Product A and institutional inquiry
BODY:
Dear Compliance Team,
I am writing as the clinical coordinator for a multi-site renal network and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where What is the establis... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the established dosing interval for ... |
SUBJECT: Supply and experience review of Product A and institutional contract enquiry
BODY:
Dear Compliance Team,
I am the medical director of a specialist cardiovascular centre and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the o... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the oral syringe provided in the kit had illegible graduation markings making accurate dosing impossible in a specific identified batch... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Compliance Team,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I need to bring two matters to your attention. Re... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient developed deep-vein thrombosis in the left calf within 2 weeks temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
I am the market access manager evaluating regional coverage for Product A in dermatology and Product B in rheumatology outsubject services. and I am writing to formally raise two matters. The fir... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share data on the bioavailab... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. I have two separate matters to raise. Firstly regarding Product... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dos... |
SUBJECT: Urgent concern regarding Product A and Product B
BODY:
Dear Clinical Lead Pharmacist,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. I have two separate concerns to raise. The first i... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you provide a summary of clinic... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Medical Information and Safety Team,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I wish to raise two issues.... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there any guidance on dose modif... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Medical Information Team,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I am writing to report two separate issue... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with... |
SUBJECT: Dual product inquiry and report about Product A and institutional inquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
As the head of pharmacy procurement for a regional health trust and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on the long... |
SUBJECT: Distribution and side-effect profile of Product A and institutional contract enquiry
BODY:
Dear Clinical Coordinator,
I am the quality officer at a private hospital and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing inspection o... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the prefilled pen device emitted an audible click but did not deliver the full dose when activated in a specific identified batch with ... |
SUBJECT: Packaging defect and dosing question for Product A and institutional inquiry
BODY:
Dear Patient Support,
As the pharmacy director of a 500-bed tertiary hospital and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Could you provide guidanc... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide guidance on dose tapering ... |
SUBJECT: Distribution and side-effect profile of Product A and institutional contract enquiry
BODY:
Dear Regulatory Affairs,
As the head of pharmacy procurement for a regional health trust and I have two distinct issues to address. The first concerns Product A 20mg where our quality team found that the barcode on the ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the barcode on the outer packaging failed to scan at three separate pharmacy workstations in a specific identified batch with quarantin... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Product Team,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I am contacting you about two separate matters. The first is a request for cli... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What adverse reactions are listed i... |
SUBJECT: Patient feedback issueing Product A and supply inquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the clinical pharmacy specialist in a busy emergency department and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 38 year old female ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Drug Safety Department,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I wish to raise two issues. The first concern... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Could you send any recent peer-revi... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Clinical Lead Pharmacist,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I wish to raise two issues simultaneously. The first is an adverse ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Pharmacy Director,
Our hospital pharmacist network reviews dual-product regimens including Product A for infectious disease and Product B for prophylactic gastroprotection. I have two distinct concerns to raise. The first is an adverse... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient encountered a sharp drop in platelet count observed on day 7 lab work temporally associated with Product A initiation, with clinical int... |
SUBJECT: Issue reported with Product A and supply inquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the chief pharmacist at a district general hospital and I have two distinct issues to address. The first concerns Product A where The patient is a 61 year old male with non-alcoholic steatohepatitis and prediabete... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient experienced severe nausea and repeated vomiting starting on day 3 of therapy temporally associated with Product A initiation, with clinical interven... |
SUBJECT: Cross-product clinical and quality note on Product A and institutional inquiry
BODY:
Dear Adverse Event Reporting Center,
I am the clinical pharmacist for a long-term care facility and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Could... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you clarify the pregnancy category and... |
SUBJECT: Patient feedback concerning Product A and institutional inquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am the clinical lead at a geriatric medicine service and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Is there a black... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there a black box warning or regulatory s... |
SUBJECT: Safety and quality note on Product A and supply inquiry
BODY:
Dear Quality Officer,
I am the director of pharmacy for a network of community hospitals and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 61 year old male with non-alcoholic... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient complained of severe abdominal cramping and diarrhea for 3 consecutive days temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Co-therapy observation and commercial query on Product A and institutional inquiry
BODY:
Dear Product Team,
I am the chief pharmacist at a district general hospital and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically What are the documente... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the documented drug-drug interactio... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Quality and Commercial Teams,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I need to address two issues simultaneously. The first is a me... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Are there any dietary restrictions ... |
SUBJECT: Inquiry and feedback about Product A and institutional inquiry
BODY:
Dear Medical Affairs,
I am the chief pharmacist at a district general hospital and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Could you send any recent peer-reviewe... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-reviewed publ... |
SUBJECT: Comprehensive inquiry on Product A and institutional inquiry
BODY:
Dear Drug Safety and Medical Information,
I am the chief pharmacist at a district general hospital and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory commi... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the recommended storage tempe... |
SUBJECT: Safety and quality note on Product A and Product B
BODY:
Dear Quality Officer,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. I have two distinct issues to raise. The first is an adverse reaction my patient has been ex... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient observed hallucinations and confusion beginning on day 4 of the regimen temporally associated with Product A initiation, with clinical i... |
SUBJECT: Inquiry and feedback about Product A and institutional contract enquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am the prescribing advisor for a mental health trust and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where the temperature indicator strip inside the shipping box had turned irreversibly red, indicating cold-chain breach in a specific identif... |
SUBJECT: Labeling error and clinical query about Product A and institutional contract enquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the medical director of a specialist cardiovascular centre and I am writing to formally raise two separate matters. The first is a product quality concern identified during ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the aluminum foil backing peeled away too easily, compromising the integrity of individual blisters in a specific identified batch with... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Pharmacovigilance Team,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. and I am writing to report two separate issues. The first involves Produc... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Joint product evaluation and safety report for Product A and institutional inquiry
BODY:
Dear Medical Affairs,
I am the medical director of a specialist cardiovascular centre and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Does Product... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require premedication with an... |
SUBJECT: Clarification sought on Product A and institutional contract enquiry
BODY:
Dear Medical Information Team,
I am the ward manager on a busy medical unit and I have two distinct issues to address. The first concerns Product A 25mg where our quality team found that the child-resistant cap failed to engage properl... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where the child-resistant cap failed to engage properly, raising serious safety concerns for household storage in a specific identified batch... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Patient Support,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. I have two separate matters to raise. Firstly regarding Product A I w... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal functio... |
SUBJECT: Urgent concern regarding Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
As the formulary coordinator for a 300-bed community hospital, I manage requests for Product A in the respiratory clinic and Product B in the rheumatology service. I have two separate matters to raise. Firstly rega... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide the pharmacokinetic ... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Medical Affairs,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease management. I have two separate matters to raise. ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share the individual-reporte... |
SUBJECT: Observation during use of Product A and institutional inquiry
BODY:
Dear Drug Safety Department,
As the head of pharmacy procurement for a regional health trust and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Please provide the recomm... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the recommended storage tempe... |
SUBJECT: Follow-up needed for Product A and institutional inquiry
BODY:
Dear Regulatory Affairs,
I am the medical director of a specialist cardiovascular centre and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory committee is consid... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide the maximum recommended da... |
SUBJECT: Distribution and side-effect profile of Product A and supply inquiry
BODY:
Dear Adverse Event Reporting Center,
I am the clinical pharmacy specialist in a busy emergency department and I am contacting you regarding two separate topics. The first is a safety report for Product A where The subject is a 55 year ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient had an anaphylactic reaction with throat swelling and difficulty breathing temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I need to address two sep... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal functio... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Medical and Commercial Teams,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. I have two distinct concerns to raise. The first is an adverse react... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient noticed dark tarry stools indicating possible gastrointestinal bleeding after 8 days temporally associated with Product A initiation, wi... |
SUBJECT: Patient feedback concerning Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the senior consultant at Global Health Partners advising on the combined formulary placement of Product A for oncology supportive care and Product B for nutritional supplementation. and I wish to raise t... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you confirm the shelf life and ... |
SUBJECT: Integrated feedback regarding Product A and supply inquiry
BODY:
Dear Quality Officer,
I am the quality officer at a private hospital and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 41 year old female with asthma and season... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient experienced profound fatigue and muscle weakness after 6 days of treatment temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. and I am writing to formally raise two ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is Product A approved for pediatric ... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Clinical Coordinator,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. I have two separate matters to raise. Firstly r... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on Product A u... |
SUBJECT: Co-therapy observation and commercial query on Product A and supply inquiry
BODY:
Dear Pharmacy Director,
As the formulary coordinator for a 300-bed community hospital and I am contacting you regarding two separate topics. The first is a safety report for Product A where The individual is a 82 year old female... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervention taken, q... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Patient Support,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. I have two distinct concerns to raise. The first is an adverse reaction my pati... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient noticed significant peripheral edema in both lower limbs after 1 week of use temporally associated with Product A initiation, with clini... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Medical and Commercial Teams,
Our hospital pharmacist network reviews dual-product regimens including Product A for infectious disease and Product B for prophylactic gastroprotection. and I need to address two separate issues. Regarding Produc... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide a summary of clinica... |
SUBJECT: Market access and patient impact of Product A and institutional contract enquiry
BODY:
Dear Medical Affairs,
I am the director of pharmacy for a network of community hospitals and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 50mg where several tablets ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where several tablets were chipped along the edges and had an off-white discoloration inconsistent with the product specification in a specif... |
SUBJECT: Co-therapy observation and commercial query on Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I need to addres... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What are the documented drug-drug i... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Patient Support,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outsubject pharmacies. and I am formally reporting two concerns. The fir... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed new-onset atrial fibrillation within 72 hours temporally associated with Product A initiation, with clinical intervention and ... |
SUBJECT: Complex issue involving Product A and supply inquiry
BODY:
To Whom It May Concern,
I am the medical director of a residential care home group managing over 400 elderly residents and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 70 year old... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from insomnia that progressed to near-total sleep deprivation over 1 week temporally associated with Product A initiation, with clinical in... |
SUBJECT: Clinical observation with Product A and institutional inquiry
BODY:
To Whom It May Concern,
I am the clinical pharmacist for a long-term care facility and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Can you provide the pharmacokinetic ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide the pharmacokinetic profile ... |
SUBJECT: Clinical observation with Product A and institutional inquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the lead clinical pharmacist at a regional oncology unit and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Are there any co... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any contraindications for Product ... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I need to bring two matters to your attention. Regardin... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinica... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Pharmacy Director,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I wish to raise two issues. The first concerns medical information ab... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you share the patient-reported ... |
SUBJECT: Issue reported with Product A and supply inquiry
BODY:
Dear Medical Director,
I am the chief pharmacist at a district general hospital and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 63 year old female with osteoporosis. Sh... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient reported dizziness and orthostatic hypotension after 2 doses temporally associated with Product A initiation, with clinical intervention taken, qual... |
SUBJECT: Combined quality and clinical report for Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. and I am writing to formally ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you clarify whether Product A is... |
SUBJECT: Request for details about Product A and Product B
BODY:
Dear Clinical Lead Pharmacist,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. I have two separate matters to raise. Firstly regarding Product A I would ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any contraindications for ... |
SUBJECT: Complex issue involving Product A and institutional contract enquiry
BODY:
Dear Post-Market Surveillance,
I am the chief pharmacist at a district general hospital and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing inspection of ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the outer box was water-damaged during transit, affecting the legibility of dosage instructions printed on the flap in a specific ident... |
SUBJECT: Patient feedback concerning Product A and Product B
BODY:
Dear Drug Safety Department,
As the formulary coordinator for a 300-bed community hospital, I manage requests for Product A in the respiratory clinic and Product B in the rheumatology service. and I am writing to report two separate issues. The first i... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient showed signs of acute renal dysfunction with rising creatinine after 5 days temporally associated with Product A initiation, with clinic... |
SUBJECT: Safety and quality note on Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. and I wish to raise two issues simultaneously. The first is an adverse event... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient had an anaphylactic reaction with throat swelling and difficulty breathing temporally associated with Product A initiation, with clinica... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I wish to raise two issues. The first conce... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Could you provide the maximum recom... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Customer Support,
Our integrated care system manages patients discharged on Product A for heart failure and Product B for chronic pain across 15 community clinics. and I am contacting you about two separate matters. The first is a reques... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there any guidance on Product A ... |
SUBJECT: Urgent problem regarding Product A and institutional inquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the lead clinical coordinator for a hospice network and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory com... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dose for Pr... |
SUBJECT: Request for details about Product A and institutional contract enquiry
BODY:
Dear Medical Director,
I am the director of pharmacy for a network of community hospitals and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the refill cartridge for the in... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the refill cartridge for the inhaler device failed to lock into place and fell out upon inversion in a specific identified batch with q... |
SUBJECT: Multi-faceted concern about Product A and Product B
BODY:
Dear Medical Information Team,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I am writing to formally report two distinct matters. Regarding Product ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What are the documented drug-drug i... |
SUBJECT: Complex issue involving Product A and supply inquiry
BODY:
Dear Quality and Commercial Teams,
I am the ward manager on a busy medical unit and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 53 year old female with endometriosis and chronic pelvi... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient had an episode of syncope approximately 6 hours post-dose temporally associated with Product A initiation, with clinical intervention taken, qualify... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I am writing to raise two distinct concerns. The first is a clin... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-revie... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Quality and Commercial Teams,
Our integrated care system manages patients discharged on Product A for heart failure and Product B for chronic pain across 15 community clinics. and I am writing to formally raise two matters. The first c... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide a summary of clinica... |
SUBJECT: Administrative and medical query on Product A and institutional contract enquiry
BODY:
Dear Customer Support,
I am the chief pharmacist at a district general hospital and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the refill cartridge for the in... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the refill cartridge for the inhaler device failed to lock into place and fell out upon inversion in a specific identified batch with q... |
SUBJECT: Administrative and medical query on Product A and institutional inquiry
BODY:
Dear Quality Assurance Team,
I am the clinical pharmacist for a long-term care facility and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where What is the establis... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the established dosing interval for ... |
SUBJECT: Product quality and adverse experience with Product A and supply inquiry
BODY:
Dear Clinical and Supply Chain Team,
As the head of pharmacy procurement for a regional health trust and I have two distinct issues to address. The first concerns Product A where The patient is a 58 year old male with COPD. He expe... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the subject experienced acute chest pain radiating to the left arm within 4 hours of the dose temporally associated with Product A initiation, with clinical int... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Compliance Team,
I am writing as the clinical pharmacist for a long-term care facility where residents receive Product A for chronic heart failure and Product B for osteoporosis prevention. and I wish to raise two issues. The first con... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you clarify whether Product A i... |
SUBJECT: Healthcare provider memo on Product A and institutional contract enquiry
BODY:
Dear Adverse Event Reporting Center,
As the head of pharmacy procurement for a regional health trust and I have two distinct issues to address. The first concerns Product A 10mg where our quality team found that the accompanying su... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the accompanying individual leaflet was missing entirely from 2 of the 5 cartons delivered in a specific identified batch with quaranti... |
SUBJECT: Administrative and medical query on Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same individual episodes. and I am writing to formally raise two matters. The first... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What adverse reactions are listed in... |
SUBJECT: Joint product evaluation and safety report for Product A and institutional contract enquiry
BODY:
Dear Patient Support,
I am the head of formulary and medicines optimisation for an integrated care board and I am writing to formally raise two separate matters. The first is a product quality concern identified ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the cap of the dropper bottle was cross-threaded and could not be sealed tightly after opening in a specific identified batch with quar... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Clinical Coordinator,
I am the market access manager evaluating regional coverage for Product A in dermatology and Product B in rheumatology outpatient services. and I wish to raise two issues. The first concerns medical information ab... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is Product A approved for pediatric... |
SUBJECT: Product quality and adverse experience with Product A and institutional inquiry
BODY:
Dear Pharmacy Director,
I am writing as the clinical coordinator for a multi-site renal network and I have two distinct issues to address. Regarding Product A for formulary evaluation, Are there any dietary restrictions or f... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any dietary restrictions or food i... |
SUBJECT: Safety and quality note on Product A and institutional contract enquiry
BODY:
Dear Product Team,
I am the clinical pharmacist for a long-term care facility and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 20mg where the desiccant packet inside the bott... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where the desiccant packet inside the bottle was torn and the contents had spilled over the tablets in a specific identified batch with quara... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Customer Support,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. and I need to bring two matters to your attention... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Distribution and side-effect profile of Product A and supply inquiry
BODY:
Dear Customer Support,
I am the clinical pharmacy specialist in a busy emergency department and I wish to bring two matters to your attention. The first is an adverse reaction report issueing Product A where The patient is a 61 year ol... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient had an anaphylactic reaction with throat swelling and difficulty breathing temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Packaging defect and dosing question for Product A and institutional inquiry
BODY:
Dear Medical Affairs,
I am the director of pharmacy for a network of community hospitals and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Is there any guidance on do... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on dose modification f... |
SUBJECT: Combined quality and clinical report for Product A and Product B
BODY:
Dear Clinical Affairs,
I am the medical director of a residential care home group managing over 400 elderly residents across four facilities, several of whom are on Product A for hypertension and Product B for hyperlipidemia. and I need to... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed bilateral hearing loss and persistent tinnitus after 11 days temporally associated with Product A initiation, with clinical in... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I am writing to raise two disti... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require premedication... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Patient Safety and Market Access Team,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I need to address two separate issues. Regarding Product A our ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dos... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Quality and Commercial Teams,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I need to address two separate issues. Regarding Product A... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recom... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I need to bring two matters to ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinica... |
SUBJECT: Safety and quality note on Product A and institutional inquiry
BODY:
Dear Medical Affairs,
I am writing as the clinical coordinator for a multi-site renal network and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Could you send any recen... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-reviewed publ... |
SUBJECT: Joint product evaluation and safety report for Product A and institutional contract enquiry
BODY:
Dear Regulatory Affairs,
I am the director of pharmacy for a network of community hospitals and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the cart... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the cartridge contained visible fibrils or precipitate that should not have been present in a specific identified batch with quarantine... |
SUBJECT: Patient feedback concerning Product A and Product B
BODY:
Dear Customer Support,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I wish to bring two issues to your attention. The first is a medical information... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal functio... |
SUBJECT: Comprehensive inquiry on Product A and institutional inquiry
BODY:
Dear Drug Safety and Medical Information,
I am the clinical pharmacist for a long-term care facility and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically What are the infusi... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the infusion instructions if Produc... |
SUBJECT: Clarification sought on Product A and institutional contract enquiry
BODY:
Dear Clinical Coordinator,
I am the medical director of a residential care home group managing over 400 elderly residents and I have two distinct issues to address. The first concerns Product A 100mg where our quality team found that t... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where the desiccant packet inside the bottle was torn and the contents had spilled over the tablets in a specific identified batch with quara... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Post-Market Surveillance,
Our hospital pharmacist network reviews dual-product regimens including Product A for infectious disease and Product B for prophylactic gastroprotection. and I am contacting you about two separate matters. The first is a request ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What monitoring parameters are reco... |
SUBJECT: Supply and experience review of Product A and institutional contract enquiry
BODY:
Dear Clinical Coordinator,
I am the medical director of a specialist cardiovascular centre and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing ins... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the label on the outer carton displayed an incorrect batch number compared to the inner foil strip in a specific identified batch with ... |
SUBJECT: Pricing inquiry and safety signal for Product A and institutional contract enquiry
BODY:
Dear Quality and Commercial Teams,
I am the clinical lead at a geriatric medicine service and I have two distinct issues to address. The first issues Product A 20mg where our quality team found that a vial arrived with a ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where a vial arrived with a cracked neck, causing leakage of approximately 2 ml of solution in a specific identified batch with quarantined s... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.